A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

NCT07664735 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer Recurrent
Endometrial Cancer
Advanced Endometrial Cancer
Ovarian Cancer
Ovarian Cancer Recurrent
Platinum Resistant Ovarian Cancer
Endometrial Cancers

Interventions

BIOLOGICAL: OPB-201

Sponsor

Outpace Bio, Inc.